Bempegaldesleukin
Bempegaldesleukin Uses, Dosage, Side Effects, Food Interaction and all others data.
Bempegaldesleukin is under investigation in clinical trial NCT03729245 (A Study of NKTR-214 in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)).
| Trade Name | Bempegaldesleukin |
| Generic | Bempegaldesleukin |
| Bempegaldesleukin Other Names | Bempegaldesleukin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Bempegaldesleukin
